Site-specific genomic integration produces therapeutic Factor IX levels in mice
- 15 October 2002
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 20 (11) , 1124-1128
- https://doi.org/10.1038/nbt753
Abstract
We used the integrase from phage φC31 to integrate the human Factor IX (hFIX) gene permanently into specific sites in the mouse genome. A plasmid containing attB and an expression cassette for hFIX was delivered to the livers of mice by using high-pressure tail vein injection. When an integrase expression plasmid was co-injected, hFIX serum levels increased more than tenfold to ∼4 μg/ml, similar to normal FIX levels, and remained stable throughout the more than eight months of the experiment. hFIX levels persisted after partial hepatectomy, suggesting genomic integration of the vector. Site-specific integration was proven by characterizing and quantifying genomic integration in the liver at the DNA level. Integration was documented at two pseudo-attP sites, native sequences with partial identity to attP, with one site highly predominant. This study demonstrates in vivo gene transfer in an animal by site-specific genomic integration.Keywords
This publication has 18 references indexed in Scilit:
- Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vectorNature Biotechnology, 2002
- Epstein–Barr Virus/Human Vector Provides High-Level, Long-Term Expression of α1-Antitrypsin in MiceMolecular Therapy, 2001
- Site-Specific Genomic Integration in Mammalian Cells Mediated by Phage φC31 IntegraseMolecular and Cellular Biology, 2001
- Efficient Expression of Naked DNA Delivered Intraarterially to Limb Muscles of Nonhuman PrimatesHuman Gene Therapy, 2001
- Linear DNAs Concatemerize in Vivo and Result in Sustained Transgene Expression in Mouse LiverMolecular Therapy, 2001
- Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedureGene Therapy, 2000
- Inclusion of the Hepatic Locus Control Region, an Intron, and Untranslated Region Increases and Stabilizes Hepatic Factor IX Gene Expression in Vivo but Not in VitroMolecular Therapy, 2000
- High Levels of Foreign Gene Expression in Hepatocytes after Tail Vein Injections of Naked Plasmid DNAHuman Gene Therapy, 1999
- Real time quantitative PCR.Genome Research, 1996
- Analysis of the integration function of the streptomycete bacteriophage φC31Journal of Molecular Biology, 1991